QuiaPEG Pharmaceuticals Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 3044.3%.

Top 16 shareholders own 19.26% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
10.7%	Iskander World AB	8,000,000	€51.3k	0%	no data
4.29%	Nordnet AB (publ), Asset Management Arm	3,193,802	€20.5k	0%	no data
2.72%	Avanza Fonder AB	2,027,138	€13.0k	0%	no data
0.71%	Futur Pension Försäkringsaktiebolag, Asset Management Arm	530,719	€3.4k	0%	no data
0.33%	Gryningskust FÖRvaltning Ab	242,966	€1.6k	0%	no data
0.11%	Berth Von Kantzows Stiftelse, Endowment Arm	81,582	€523.0	0%	0.04%
0.1%	Marek Kwiatkowski	76,369	€489.6	0%	no data
0.064%	Rune Loderup	47,856	€306.8	0%	no data
0.056%	Johan von Kantzow	41,667	€267.1	0%	no data
0.055%	Thomas Trumstedt	41,000	€262.8	0%	no data
0.052%	Marcus Bosson	38,823	€248.9	0%	no data
0.028%	Lars Linzander	20,975	€134.5	0%	no data
0.0054%	Otradama & Partners AB	4,000	€25.6	0%	no data
0.0027%	Stig Pedersen	2,000	€12.8	0%	no data
0.0021%	Skeppskajen AB	1,560	€10.0	0%	no data
0.0002%	Vidar Wendel-Hansen	150	€1.0	0%	no data